# Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma

> **NCT00003778** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 37 (actual)

## Conditions studied

- Ovarian Cancer
- Sarcoma

## Interventions

- **DRUG:** dolastatin 10

## Key facts

- **NCT ID:** NCT00003778
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04
- **Primary completion:** 2000-07
- **Final completion:** —
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2013-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003778, "Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00003778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*